Market size, share and growth analysis by product type, technology, application and end user, across all major regions and key countries, with forecasts for 2024–2033. The competitive landscape profiles 15+ companies.
The global apheresis equipment market was valued at USD 4.67 Bn in 2024 and is projected to reach USD 13.17 Bn by 2033, growing at a CAGR of 12.2%. Europe is the largest regional market and Asia-Pacific is growing fastest.
Reports Description
As per the current market research conducted by the CMI Team, the global Apheresis Equipment Market is expected to record a CAGR of 12.2% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 4,673.2 Million. By 2033, the valuation is anticipated to reach USD 13,169.1 Million.
Global Apheresis Equipment Market 2024–2033 (By Million)
The apheresis equipment market comprises devices used to separate specific blood components for therapeutic purposes. These devices are critical in treating various medical conditions such as autoimmune disorders, neurological diseases, and haematological malignancies.
Apheresis procedures involve extracting blood from patients, separating the targeted component (plasma, platelets, or white blood cells) using centrifugation or membrane filtration, and returning the remaining blood components to the patient.
The market is driven by technological advancements, expanding applications across different medical specialties, and increasing demand for specific blood components for transfusion and therapeutic purposes, supported by growing healthcare infrastructure globally.
The Apheresis Equipment Market presents significant growth opportunities due to several factors:
Rising Prevalence of Chronic Diseases: The increasing incidence of autoimmune disorders, haematological diseases, and neurological conditions necessitates therapeutic apheresis, driving the market growth.
Technological Advancements: Continuous innovations in apheresis equipment, such as enhanced automation and improved safety features, are improving treatment outcomes and expanding the market.
Growing Demand for Blood Components: Hospitals and blood centers require apheresis equipment to meet the rising demand for specific blood components like plasma and platelets, driven by increasing transfusion needs.
Expanding Applications in Medical Treatments: Apheresis is increasingly utilized in treating a broader spectrum of medical conditions, including metabolic disorders and oncology, further boosting market demand.
Emerging Markets Expansion: Opportunity exists in expanding into emerging markets where healthcare infrastructure is improving, and there is rising awareness and adoption of advanced medical treatments like apheresis.
Personalized Medicine and Precision Therapies: Apheresis equipment can play a crucial role in personalized medicine by facilitating targeted therapies and precision medicine approaches, presenting a significant opportunity for market growth and innovation.
Integration with Digital Health Technologies: There is an opportunity to integrate apheresis equipment with digital health technologies such as telemedicine platforms and remote monitoring devices. This integration can enhance patient management, optimize treatment protocols, and improve operational efficiencies, thereby driving adoption and market expansion in the era of digital healthcare solutions.
Apheresis Equipment Market - Mergers and Acquisitions
The Apheresis Equipment Market has seen several mergers and acquisitions in recent years, with companies seeking to expand their market presence and leverage synergies to improve their product offerings and profitability. Some notable examples of mergers and acquisitions in the Apheresis Equipment Market include:
In 2023, Terumo Corporation introduced a pioneering training program aimed at enhancing cell and gene therapy manufacturers' cell collection processes. This initiative in the apheresis market aims to equip participants with advanced skills to expedite therapeutic commercialization and improve treatment outcomes.
In 2023, Fresenius Kabi AG and Lupagen Inc. entered a supply and development agreement focused on technologies designed to advance the delivery of cell and gene therapies directly to patients' bedsides. This collaboration aims to enhance therapeutic accessibility and efficacy.
In 2023, TERUMO BCT, INC. received FDA clearance for a platelet device that processes blood into platelets using a single centrifugation cycle. This innovation promises efficiency in platelet production, potentially improving patient care and medical outcomes.
These mergers and acquisitions helped companies expand their product offerings, improve their market presence, and capitalize on growth opportunities in the Apheresis Equipment Market. The trend is expected to continue as companies seek to gain a competitive edge in the market.
COMPARATIVE ANALYSIS OF THE RELATED MARKET
Apheresis Equipment Market
Medical Aesthetics Market
Genetic Engineering Market
CAGR 12.2% (Approx)
CAGR 8.4% (Approx)
CAGR 6.74% (Approx)
USD 13,169.1Million by 2033
USD 36,168.8 Million by 2033
USD 2,917.2 Million by 2033
Apheresis Equipment Market - Significant Threats
The Apheresis Equipment Market faces several significant threats that could impact its growth and profitability in the future. Some of these threats include:
Stringent Regulatory Requirements: Complex regulatory pathways for approval of apheresis devices can delay market entry and increase development costs, posing a barrier to new entrants and innovation.
High Cost of Equipment and Procedures: The substantial initial investment required for apheresis equipment, coupled with the high cost of procedures, may limit adoption and accessibility, especially in resource-constrained healthcare settings.
Competition and Pricing Pressures: Intense competition among key players and the presence of alternative therapies can lead to price wars and margin pressures, impacting profitability and market stability.
Technological Risks and Device Failures: Risks associated with technological malfunctions, device failures, or adverse events during procedures can undermine patient confidence and prompt regulatory scrutiny, damaging market reputation.
Economic Uncertainty and Healthcare Budget Constraints: Economic downturns and healthcare budget constraints can reduce healthcare spending and delay investments in new apheresis equipment, affecting market growth and adoption rates.
Category-Wise Insights:
By Product Type
Plasmapheresis Equipment: Plasmapheresis equipment separates plasma from blood components for therapeutic use in conditions like autoimmune disorders and plasma exchange therapies. Trends include advancements in automated systems and disposable kits, enhancing efficiency and reducing procedural times.
Photopheresis Equipment: Photopheresis equipment is used for extracorporeal photopheresis treatments, crucial in managing immune-mediated diseases like graft-versus-host disease (GVHD). Trends focus on improved device ergonomics and integration with digital monitoring for enhanced patient outcomes.
LDL Apheresis Equipment: LDL apheresis equipment selectively removes low-density lipoprotein (LDL) cholesterol from the blood, aiding in managing hyperlipidemia and reducing cardiovascular risk. Trends include compact and portable systems, promoting outpatient use and patient convenience.
Others: Other apheresis equipment includes systems for specific blood components like platelets or white blood cells, catering to diverse therapeutic needs. Trends involve customization for rare diseases and integration with personalized medicine approaches, driving innovation and expanding treatment options.
By Technology
Centrifugation Apheresis: Centrifugation apheresis utilizes centrifugal force to separate blood components based on their density. This technology is pivotal in extracting plasma, platelets, or white blood cells for therapeutic purposes. Recent trends include advancements in centrifuge design for improved efficiency and automation, enhancing treatment precision and patient outcomes. Centrifugation remains a cornerstone in apheresis procedures due to its robustness and versatility in clinical applications.
Membrane Filtration Apheresis: Membrane filtration apheresis employs semi-permeable membranes to selectively remove targeted blood components. This technology is integral in treating autoimmune diseases and removing low-density lipoprotein (LDL) cholesterol. Trends involve innovations in membrane materials to enhance biocompatibility and efficiency, enabling precise separation of blood constituents while minimizing side effects. Membrane filtration continues to evolve with advancements in membrane technology and device miniaturization, catering to diverse therapeutic needs.
By Application
Renal Disease: Apheresis equipment in renal disease involves removing harmful substances from the blood, such as autoantibodies in autoimmune nephritis. Trends include advancements in membrane filtration technology for efficient toxin removal and the growing adoption of therapeutic plasma exchange (TPE) in managing kidney-related complications.
Neurology: In neurology, apheresis treats disorders like Guillain-Barré syndrome by removing pathogenic antibodies. Trends include increased utilization of immunoadsorption techniques and the development of targeted therapies for neurological conditions.
Haematology: Apheresis in Hematology focuses on extracting specific blood components like stem cells for transplantation in haematological malignancies. Trends include advancements in cell separation technology and the expansion of applications to include treating disorders like sickle cell disease.
Others: Other applications encompass various medical conditions treated with apheresis, such as cardiovascular diseases and metabolic disorders. Trends involve expanding the scope of apheresis applications through personalized medicine approaches and the integration of digital health technologies for enhanced patient management.
By End Users
Hospitals: Hospitals are major users of apheresis equipment, employing it for treatments across various specialties. Trends include increasing adoption of automated systems for efficiency and expanding applications in oncology and neurology.
Ambulatory Surgical Centers (ASCs): ASCs utilize apheresis equipment for outpatient procedures, focusing on efficiency and patient comfort. Trends include growth in outpatient treatments and the adoption of portable and compact apheresis systems.
Blood Donation Centers: Blood donation centers use apheresis equipment to collect specific blood components like platelets and plasma. Trends include advancements in collection technologies and increasing demand for specific blood products.
Others: Other healthcare facilities, such as specialty clinics and research institutions, integrate apheresis equipment for specialized treatments and studies. Trends include collaborations for research advancements and expanding clinical applications beyond traditional uses.
Report Scope
Feature of the Report
Details
Market Size in 2024
USD 4,673.2 Million
Projected Market Size in 2033
USD 13,169.1 Million
Market Size in 2023
USD 4,165.1 Million
CAGR Growth Rate
12.2% CAGR
Base Year
2023
Forecast Period
2024-2033
Key Segment
By Product Type, Technology, Application, End User and Region
Report Coverage
Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options
Request tailored purchasing options to fulfil your requirements for research.
Apheresis Equipment Market - Regional Analysis
The Apheresis Equipment Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:
North America: North America leads in apheresis equipment adoption due to advanced healthcare infrastructure and high disease prevalence. Trends include an increasing focus on personalized medicine, technological innovations in automated systems, and a growing shift towards outpatient treatments in ASCs.
Europe: Europe shows steady growth with expanding applications in autoimmune disorders and haematology. Trends include stringent regulatory standards, rising investments in healthcare technology, and collaborations for clinical research and the development of novel therapies.
Asia-Pacific: Asia-Pacific exhibits rapid market expansion driven by improving healthcare access and rising chronic disease burden. Trends include growing healthcare expenditure, adoption of cost-effective apheresis technologies, and partnerships for local manufacturing and distribution to enhance accessibility.
LAMEA (Latin America, Middle East, and Africa): The LAMEA region is experiencing increasing adoption of apheresis equipment amidst developing healthcare infrastructure. Trends include rising awareness about therapeutic benefits, government initiatives to enhance healthcare access, and partnerships for technology transfer and training to support market growth.
The Apheresis Equipment Market is highly competitive, with a large number of manufacturers and retailers operating globally. Some of the key players in the market include:
Terumo BCT Inc.
Fresenius SE & Co. KGaA
Haemonetics Corporation
Asahi Kasei Medical Co. Ltd.
Baxter International Inc.
Kaneka Corporation
Braun Melsungen AG
Nikkiso Co. Ltd.
Medica S.p.A.
Miltenyi Biotec
Thermo Fisher Scientific Inc.
Hemonetics Corporation
Cerus Corporation
MacoPharma
Gambro
Others
These companies operate in the market through various strategies such as product innovation, mergers and acquisitions, and partnerships.
Emerging companies like Miltenyi Biotec and MacoPharma are leveraging innovation in apheresis equipment, focusing on advanced technologies such as automated systems and improved device integration for personalized therapies. These newcomers are expanding market horizons with novel approaches to meet evolving healthcare demands.
Established leaders such as Terumo BCT, Fresenius SE & Co. KGaA, and Haemonetics Corporation dominate the apheresis equipment market. They lead through extensive R&D investments, comprehensive product portfolios covering diverse therapeutic applications, and robust global distribution networks. These companies' strategic acquisitions and partnerships bolster their market presence and sustain their leadership positions in the competitive landscape.
Which are the driving factors of the Apheresis Equipment Market?
The key factors driving the Market are Rising Prevalence of Chronic Diseases, Technological Advancements, Growing Demand for Blood Components, Expanding Applications in Medical Treatments, Emerging Markets Expansion, Personalized Medicine and Precision Therapies, Integration with Digital Health Technologies.
Which application had the largest market share in the market?
The "Renal Disease" had the largest share in the global market for Apheresis Equipment.
Which type led the Apheresis Equipment market?
The "Plasmapheresis Equipment" category dominated the market in 2023.
Who are the key players in the Apheresis Equipment market?
The key players in the market are Terumo BCT Inc., Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd., Baxter International Inc., Kaneka Corporation, B. Braun Melsungen AG, Nikkiso Co. Ltd., Medica S.p.A., Miltenyi Biotec, Thermo Fisher Scientific Inc., Hemonetics Corporation, Cerus Corporation, MacoPharma, Gambro, Others.
Which region held the largest market share in the Apheresis Equipment market?
"North America" had the largest share in the Apheresis Equipment Market.
What is the growth rate of the Apheresis Equipment market?
The global market is projected to grow at a CAGR of 12.2% during the forecast period, 2024-2033.
How much is the Apheresis Equipment market?
The Apheresis Equipment Market size was valued at USD 4,673.2 Million in 2024.
Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping clients turn complex data into actionable business decisions.
